BioSpace News Archive

Business

Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Updates

Third fiscal quarter 2021 total revenues of $54.4 million, including net product revenue of $29.3 million Net product revenue from U.S. sales of ORGOVYX ® of $24.4 million.

January 26, 2022
·
20 min read
Biotech Beach

Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention

Recro Pharma, Inc. today announced that it has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government.

January 26, 2022
·
4 min read
FDA

Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma

Immunocore Holdings plc today announces approval from the United States Food and Drug Administration (FDA) of KIMMTRAK® (tebentafusp-tebn) for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma (mUM).

January 26, 2022
·
29 min read
Lone Star Bio

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

Ziopharm Oncology, Inc. today highlighted recent operational and corporate updates.

January 26, 2022
·
7 min read
Business

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors

Ikena Oncology, Inc. today announced the appointment of Richard Wooster, Ph.D., to its Board of Directors.

January 26, 2022
·
4 min read
Canadian study reinforces need for hip fracture prevention strategies to help reduce future fracture risks and their associated costs

Study results align with United Nations’ focus on maintaining functional independence, reinforces call for better integrated care to prevent hip fractures.

January 26, 2022
·
9 min read
Drug Development

BioTheryX Doses First Patient in Phase 1 Study Investigating Lead Protein Degrader Candidate BTX-1188

BioTheryX, Inc. today announced dosing of the first-in human Phase 1 study investigating its lead candidate BTX-1188.

January 26, 2022
·
3 min read
Business

Flatiron Health Announces RWD Partnership With Japan’s NCCHE

Flatiron Health Ⓡ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers.

January 26, 2022
·
3 min read
Business

BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board

BrainsWay Ltd., a global leader in the advanced noninvasive treatment of brain disorders, announced the addition of Professor Markus Heilig, M.D., Ph.D., to BrainsWay’s scientific advisory board.

January 26, 2022
·
5 min read
Business

Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast

Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook for 2022.

January 26, 2022
·
31 min read